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AbstrAct
Objectives To evaluate the combined effect of 
intramuscular acepromazine and methadone on tear 
production in dogs undergoing general anaesthesia for 
elective, non-ocular procedures.
Design Prospective, non-randomised, pre-post treatment 
study.
Setting Patients were recruited from a referral practice in 
the UK.
Methods Thirty client-owned dogs were enrolled in 
this study and received a combined intramuscular 
premedication of methadone (0.3 mg/kg) and 
acepromazine (0.02 mg/kg) before general anaesthesia 
for elective, non-ocular procedures. Full ophthalmic 
examination was performed and tear production was 
quantified using the Schirmer tear test-1 (STT-1). On the 
day of general anaesthesia, an STT-1 was performed 
before (STT-1a) and after (STT-1b) intramuscular 
premedication with methadone/acepromazine.
Results Using a general linear model, a significant 
effect on STT-1 results was found for premedication 
with methadone/acepromazine (P=0.013), but not eye 
laterality (P=0.527). Following premedication, there was a 
significant reduction observed in the mean STT-1 readings 
of left and right eyes between STT-1a (20.4±2.8 mm/min) 
and STT-1b (16.9±4.1 mm/min; P<0.001). Significantly 
more dogs had an STT-1 reading less than 15 mm/min in 
one or both eyes after premedication (30 per cent; 9/30 
dogs) compared with before premedication (6.7 per cent; 
2/30 dogs; P=0.042).
Conclusions An intramuscular premedication of 
methadone and acepromazine results in a decrease in tear 
production in dogs before elective general anaesthesia. 
This may contribute to the risk of ocular morbidities, such 
as corneal ulceration, particularly in patients with lower 
baseline tear production.
IntRODuCtIOn
The precorneal tear film is composed of a 
lipid, aqueous and mucin layer, and is essen-
tial for the maintenance of ocular health.1 
It provides lubrication, mechanical removal 
of debris, immunological support and nutri-
tion to the avascular cornea.2 The tear film 
also provides an optically smooth surface, 
which contributes to refraction and there-
fore optical power of the eye.1 3 The standard 
method of quantifying aqueous tear produc-
tion in veterinary practice is the Schirmer tear 
test-1 (STT-1), which measures both reflex 
and basal tear production.4 5 
Several studies have investigated the effects 
of commonly administered sedative drugs on 
tear production in dogs, as measured by the 
STT-1.6–10 An opioid combined with a tran-
quiliser or sedative agent is commonly used 
as an analgesic and to allow reduction in 
doses of sedative and anaesthetic drugs.11 12 
There are inconsistent findings regarding the 
effect on tear production following the 
administration of full μ-opioid receptor 
agonists, either alone or in combination 
with sedative or tranquilising drugs. Signif-
icant reductions6–8 and equivocal changes9 
on tear production have been observed. 
For example, in the clinical canine study by 
Dodam and others,8 intramuscular aceprom-
azine (0.03 mg/kg), a phenothiazine deriva-
tive, combined with oxymorphone (0.1 mg/
kg), a full μ-opioid receptor agonist, resulted 
in a moderate decrease in STT-1 measure-
ments from 21±2 mm/min at baseline to 
15±2 mm/min postsedation (P<0.05). In 
contrast, Biricik and others6 demonstrated 
marked reductions in tear production from 
18.34±1.94 and 18.25±1.68 mm/min at base-
line to 10.81±2.54 and 11.18±1.54 (P<0.001) 
in dogs administered only pethidine or 
fentanyl, respectively, both of which are also 
full μ-opioid receptor agonists, without the 
addition of a sedative drug.
Methadone, another full μ-opioid receptor 
agonist, is licensed in the UK as a premedi-
cation agent for dogs undergoing general 
anaesthesia. In combination with aceprom-
azine, methadone provides sedation,12 13 
reduces the minimum alveolar concentration 
of isoflurane and causes less vomiting than 
acepromazine combined with morphine.12 
To date, its effects on tear production in dogs 
have not been evaluated.
The purpose of this study was to deter-
mine the combined effect of intramuscular 
acepromazine (0.02 mg/kg) and methadone 
(0.3 mg/kg) on STT-1 results in dogs before 
general anaesthesia for elective, non-ocular 
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surgeries. The null hypothesis was that there would be no 
effect of intramuscular acepromazine and methadone on 
STT-1 readings.
MethODS
For this study informed owner consent was obtained. 
Thirty-eight client-owned dogs were recruited at a multi-
disciplinary small animal veterinary referral hospital in 
the UK.
Inclusion criteria required that all dogs be systemically 
well, unaffected by ocular disease that could affect STT-1 
results and undergoing general anaesthesia for reasons 
unrelated to ocular health. An ophthalmic exam was 
performed on all patients by an ECVO board-certified 
ophthalmologist or resident. Ophthalmic examination 
included slit-lamp biomicroscopy (SL-14 Kowa, Optimed, 
California, USA), indirect ophthalmoscopy (Heine 
Omega 120, Germany and 2.2 Panretinal Volk lens, 
Ohio, USA) and tonometry (iCare Tonovet, Finland). 
Ophthalmic examination was performed after the STT-1 
procedure to ensure no effect on STT-1 readings from 
either eyelid manipulations or photic stimulation. Dogs 
with an incipient cataract or minor fundic abnormality, 
such as inactive chorioretinal scarring, were included. 
Exclusion criteria included an initial baseline STT-1 of 
less than 10 mm/min, adnexal, ocular surface or intra-
ocular disease with potential for modifying STT-1 results, 
patients on topical or systemic medication and any patient 
with an adverse reaction to the STT-1 procedure. Where 
investigators were available, dogs admitted the day before 
surgery had an additional STT-1 (STT-1h) performed 
within two hours of admission to the hospital on the day 
before premedication, to evaluate the effects of overnight 
hospitalisation on STT-1 results. No drugs were admin-
istered to these patients overnight. The remaining dogs 
were either hospitalised overnight without an STT-1h 
reading, or admitted on the day of their procedure.
All STTs were performed by the first author. Measure-
ments were taken bilaterally starting with the left eye, 
followed by the right eye. A standardised 5 mm×35 mm 
strip of sterile Whatman no. 41 filter paper from a single 
batch (STT strips, Schering-Plough Animal Health, 
Uxbridge, Middlesex, UK) was folded at the notch within 
the sachet before placement. The strip was placed into the 
conjunctival fornix at the lateral third of the lower eyelid, 
ensuring contact with the corneal surface. Migration of 
tears via capillary action onto the strip was measured in 
millimetres at 60 seconds.
On the day of surgery, all dogs underwent two STT-1 tear 
tests: an initial baseline STT-1 (STT-1a) between 7:00 and 
8:00 hours to minimise variation resulting from circadian 
rhythms, and a second STT-1 (STT-1b) after receiving 
a combined intramuscular premedication of aceprom-
azine (0.02 mg/kg; PromAce, Boehringer Ingelheim 
Vetmedica, St Joseph, Missouri, USA) and methadone 
(0.3 mg/kg; Comfortan, Dechra Veterinary Products, 
Shropshire, UK), before general anaesthesia. STT-1b 
was performed between 8:30 and 14:00 hours. Timing 
of premedication, and therefore STT-1b measurement, 
was dependent on the daily hospital schedule. The times 
from premedication to STT-1b (‘premed to STT-1b’), and 
from STT-1a to STT-1b (‘time between STT-1a and STT-1b’) 
were recorded (figure 1).
Sample size calculations indicated that a population 
of more than 12 dogs per group would give a statistical 
power of 0.9 with an alpha of 0.05 for detecting a change 
in mean STT-1 results of 5 mm after premedication, 
based on changes in STT-1 readings in dogs premedi-
cated with medetomidine and butorphanol.10 Data were 
analysed using Minitab 17 Statistical Software (Minitab, 
State College, Pennsylvania, USA). Deviations from 
assumptions of normality were assessed using graphical 
displays, including histograms and Q-Q plots, and the 
Anderson-Darling test. Parametric data are presented as 
mean (±SD) and non-parametric data are presented as 
median (range).
Data for STT-1 readings were measured on the left 
and right eyes. A general linear model was used to assess 
for dog identity and eye laterality as random effects and 
premedication as a fixed effect, with STT-1 measure-
ment as the dependent variable. Eye laterality was nested 
within dog identity to account for lack of independence 
Figure 1 Timeline of events illustrating admission to hospital, Schirmer tear test (STT)-1h, STT-1a, intramuscular 
premedication ('premed') with methadone (0.3mg/kg) and acepromazine (0.02 mg/kg) and STT-1b.
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between these factors. An interaction term for dog iden-
tity with premedication was included in the model. A 
general linear model with a Tukey post hoc method was 
also used on any hospitalised dogs with STT-1h readings 
to evaluate changes in STT-1 readings, with input as 
above but adding measurement point (STT-1h, STT-1a 
or STT-1b) as a fixed effect. Times ‘premed to STT-1b’ 
and ‘time between STT-1a and STT-1b’ were not included 
as terms in these models as they were defined by dog 
identity and produced a multicollinearity error. Instead, 
in order to investigate potential effects of hospitalisation 
on mean (average between the left and right eye) STT-1 
readings, Pearson’s correlation was calculated to investi-
gate whether mean STT-1b results were affected by either 
‘time between STT-1a and STT-1b’ or ‘premed to STT-1b’ time. 
Statistical significance was set at P<0.05.
In order to assess the clinical relevance of any changes 
following premedication, the Fisher’s exact test was used 
to compare proportions of dogs with at least one eye with 
an STT-1 reading less than a clinically defined cut-off 
value of 15 mm/min before and after premedication, and 
during hospitalisation.
ReSultS
Of 38 recruited dogs, 8 dogs were excluded due to 
abnormal ophthalmic examination (n=4), baseline STT-1 
result of less than 10 mm/min (n=2), distress during the 
STT-1 procedure (n=1) or additional systemic medica-
tion administered before premedication (n=1). Thirty 
dogs were included in the data analysis. Breeds and 
signalments were mixed and are outlined in table 1.
Of 30 dogs, 21 were hospitalised overnight before 
premedication, and 12 of those that were hospitalised 
were assessed for STT-1h (figure 1). The time between 
STT-1h and STT-1a was 19 (16–21) hours. The ‘time between 
STT-1a and STT-1b’ was 110 (35–430) minutes and ‘premed 
to STT-1b’ was 35 (20–80) minutes. Following premedi-
cation, there was a significant reduction observed in the 
mean STT-1 readings between STT-1a (20.4±2.8 mm/
min) and STT-1b (16.9±4.1 mm/min; P<0.001, table 1, 
figure 2).
The general linear model indicated an effect on 
STT-1 reading of dog identity (P=0.008), premedication 
(P<0.001) and an interaction between dog with premed-
ication (P=0.013), but not laterality of the eye (P=0.527). 
The adjusted R2 for this model was 68.9 per cent.
Significantly more dogs had STT-1b readings of less 
than 15 mm/min in at least one eye (n=9/30; 30 per cent), 
compared with STT-1a (n=2/30; 6.7 per cent) (P=0.042). 
Of the nine dogs with STT-1b readings of less than 
15 mm/min, seven were bilateral and breeds represented 
were mixed: French Bulldog (n=1), English Springer 
Spaniel (n=1), Labrador (n=2), crossbreed (n=2), Cava-
lier King Charles Spaniel (n=1), Tibetan Terrier (n=1) 
and Staffordshire Bull Terrier (n=1).
There was no statistically significant correlation between 
the change from ‘mean STT-1a to STT-1b’ readings and the 
time from ‘premed to STT-1b’ (P=0.771), or between the 
‘mean STT-1a to STT-1b’ and the ‘time between STT-1a and 
STT-1b’ (P=0.050, figure 3).
To evaluate the effects of hospitalisation, further tests 
were performed on subgroups. There was no significant 
difference when comparing STT-1a readings using a 
2-sample t-test for hospitalised (n=21/30) versus non-hos-
pitalised (n=9/30) dogs (mean STT-1a: 19.9±2.88 mm/
min; 21.5±2.29 mm/min, respectively; P=0.129). Separate 
general linear models similar to that described previously 
for all hospitalised dogs (n=21) and non-hospitalised 
dogs (n=9) both indicated an effect on STT-1 reading of 
premedication (P=0.001 and P=0.007, respectively) but 
not laterality of the eye (P=0.334 and P=0.972, respec-
tively). The adjusted R2 for these models was 69.1 per 
cent and 68.6 per cent, respectively.
For hospitalised dogs with an STT-1h reading 
(n=12/30), a general linear model indicated an effect on 
STT-1 reading of dog identity (P=0.018), and measure-
ment point of STT-1 reading (STT-1h, STT-1a or STT-1b; 
P<0.001), but not the laterality of the eye (P=0.725). The 
adjusted R2 for this model was 58.2 per cent. Coefficients 
for measurement points were significant for STT-1h 
(2.861; P<0.001) and STT-1b (−2.931; P<0.001) indi-
cating that these time points were associated with signifi-
cant changes in the average STT-1 measurement (0.069; 
P=0.895), but not STT-1a.
There was no statistical difference in the number of 
dogs with an STT-1 result less than 15 mm/min between 
STT-1h (n=0/12) and STT-1a (n=2/30; P=1), although 
both dogs with an STT-1a result of less than 15 mm/min 
were hospitalised overnight.
DISCuSSIOn
The results of this study demonstrate a reduction in tear 
production, and an increased number of dogs with an 
STT-1 reading of less than 15 mm/min, after intramus-
cular administration of acepromazine (0.02 mg/kg) and 
methadone (0.3 mg/kg) in dogs undergoing elective 
anaesthesia. It is widely accepted that the STT-1 reading 
in clinically normal dogs should be greater than 15 mm/
min.4 14–18 While clinically normal dogs can have STT-1 
readings of less than 15 mm/min without apparent ocular 
pathology, the reduction in tear production caused by 
the administration of a sedative and opioid may be suffi-
cient to cause desiccation of the corneal surface and 
subsequent ulceration, particularly in dogs with a lower 
baseline STT-1 value or other predisposing factor.
To the authors’ knowledge, the effects of aceproma-
zine and methadone on tear production have not been 
reported, despite the frequency of use of this combina-
tion in clinical practice in the UK. Currently, there is 
conflict in the literature about the effects of full μ-agonist 
opioids on tear production. Mouney and others9 found 
no significant changes in tear production following 
general anaesthesia in dogs administered either 
acepromazine (0.05 mg/kg) or morphine (1 mg/kg), a 
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full μ-opioid agonist. In contrast, fentanyl and pethidine, 
which are also full μ-opioid agonists, have been shown to 
reduce tear production as sole agents without the added 
effect of a sedative drug.6 A retrospective study also 
identified transdermal fentanyl administration as a risk 
factor for development of corneal ulceration in dogs that 
have undergone general anaesthesia,19 although STT-1 
measurements were not performed. Both fentanyl and 
pethidine, unlike methadone and morphine, are selec-
tive serotonin reuptake inhibitors, which may increase 
vasoconstriction, and pethidine is also anticholinergic, 
which directly reduces lacrimation.20 21 These factors 
may contribute to the more profound reduction in 
tear production seen with these drugs than with either 
morphine9 or methadone, from the data. However, the 
results of this study are consistent with previous clinical 
studies that have demonstrated decreased tear produc-
tion in dogs following administration of a full μ-opioid 
agonist combined with a sedative drug.8 22 Both Dodam 
and others8 and Ghaffari and others22 demonstrated a 
greater decrease in STT-1 readings in dogs given combi-
nations of xylazine/butorphanol or chlorpromazine/
morphine, respectively, compared with each drug being 
administered separately. It is difficult to determine 
whether the decreased tear production seen in this 
study is the result of synergism of drug action between 
acepromazine and methadone or a single drug effect, 
however the authors speculate that synergism is present 
because combining acepromazine and methadone has 
been shown to provide more profound sedation than 
either drug administered individually.12
Dodam and others8 proposed the following four mech-
anisms of action for the effect of sedatives/opioids on 
tear production: more effective antinociception, modi-
fication of central autonomic effect, reduced vascular 
supply to the tear glands caused by vasodilation or 
direct impact of the drugs on the glandular metabo-
lism and local responses to stimuli. As neural control is 
the primary factor regulating tear production,23 central 
nervous system depression caused by opioids may have 
the most significant impact on tear production.
Breeds that demonstrated an STT-1b reading of less 
than 15 mm/min were mixed and there was no clear breed 
predilection. Dogs were not excluded from this study on 
the basis of age. Hartley and others24 demonstrated a 
decrease of 0.4 mm/year in STT-1 results obtained from 
a cross-sectional population dogs between 9 months and 
11 years of age. A wide age range was represented in 
the study population, and in those patients with STT-1b 
results of less than 15 mm/min (52 (19–111) months). 
Diurnal variation was limited as much as possible, as 
previous studies have demonstrated circadian rhythms 
in canine tear production.25 26 Hartley and others24 
demonstrated an increase of 0.7 mm when the STT-1 was 
performed a total of four times in one day between 10:00 
and 16:00 hours. Similarly, Giannetto and others25 also 
demonstrated a nocturnal acrophase in STT-1 values of 
normal Beagle dogs. Therefore, the STT-1 readings in 
the current study could have become affected by a slight 
increase due to the diurnal effect. Had this effect been 
taken into consideration, the lowering of STT-1 readings 
in association with administration of acepromazine/
methadone may have been greater than reported here.
A limitation of this study is the lack of a control group 
to evaluate the effect of hospitalisation itself on the study 
population. Hospitalisation may affect tear produc-
tion due to increased sympathetic drive in a hospital 
setting and subsequently decreased lacrimation, which is 
controlled by the parasympathetic nervous system. Chan-
dler and others27 demonstrated significantly reduced 
STT-1 results in clinically unwell dogs hospitalised in an 
intensive care unit, although the effects on STT-1 may 
have resulted from illness, drug effects or a direct result 
of the hospitalisation itself. In this study, STT-1h was 
Figure 2 Comparison of mean Schirmer tear test (STT)-
1 results (mm/min) in 30 dogs before (STT-1a) and after 
(STT-1b) administration of acepromazine (0.02 mg/kg) and 
methadone (0.3 mg/kg). There was a significant decrease in 
STT-1 results after acepromazine/methadone administration. 
Box represents the IQR with median value and whiskers at 
the 10th and 90th percentiles (significance set at P<0.05).
Figure 3 Scatterplot of time between Schirmer tear test 
(STT)-1a and STT-1b (minutes) vs change in mean STT-1 
result (mm/min). Results show no clear correlation between 
the variables.
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measured where possible to provide a true baseline STT-1 
measurement on the dogs that were hospitalised over-
night before premedication the following day because 
the authors felt that taking that a ‘baseline’ tear reading 
after a night of hospitalisation could be inaccurate. 
This population was not statistically powered because 
it was the secondary outcome of the study and not the 
primary objective for which data collection was ethically 
approved. Additionally, deriving statistical significance 
from this subpopulation was not possible without a pilot 
study and subsequent power calculation because, to the 
authors’ knowledge, there are currently no peer-reviewed 
publications evaluating the effect of hospitalisation on 
clinically normal, non-medicated dogs on which to base 
a sample size calculation. While overnight hospitalisation 
in this study did significantly reduce tear production in 
the group of 12 hospitalised dogs with STT-1h readings, 
there were further reductions in STT-1 readings after 
acepromazine/methadone administration. In addition, 
there were significant reductions in STT-1 readings 
after acepromazine/methadone in both hospitalised 
and non-hospitalised groups. The authors did not find 
a significantly increased number of dogs with an STT-1 
of less than 15 mm/min in one or both eyes after hospi-
talisation; however, this study may have lacked statistical 
power to separate the effect of hospitalisation alone. It 
should be noted that both dogs with an STT-1a reading 
of less than 15 mm/min had been hospitalised overnight 
before assessment. Additionally, lack of statistical power 
meant that the authors were unable to prove an associa-
tion between change in STT-1 readings and ‘time between 
STT-1a and STT-1b’ (figure 3), however the results did 
approach statistical significance. The authors are partic-
ularly interested in this hospitalisation effect, since it has 
not been thoroughly investigated or reported previously, 
and it warrants further clarification based on the results.
An additional limitation of this study is the time of 
35 (20–80) minutes between premedication and subse-
quent measurement of STT-1b. Clinical studies by Bitti 
and others13 and Monteiro and others12 have demon-
strated the onset of sedation following acepromazine/
methadone administration within 15 min that lasts for 
over 120 min. The authors believe that tear production 
would likewise be affected for the duration of this period. 
It should be noted, however, that the degree of sedation 
achieved following the administration of acepromazine/
methadone is variable. Future research could examine 
the effect of methadone on tear production, used either 
alone or in combination with other commonly used seda-
tives, alongside objective sedation scoring to qualify this 
further.
COnCluSIOn
When administered intramuscularly, the combination of 
acepromazine (0.02 mg/kg) and methadone (0.3 mg/
kg) results in a decrease in tear production and reduces 
STT-1 results to less than 15 mm/min in at least one eye 
in 30 per cent of dogs undergoing elective general anaes-
thesia. Intramuscular combinations of acepromazine and 
methadone in dogs may add to the risk of ocular morbidi-
ties, such as corneal ulceration, in susceptible individuals.
Acknowledgements The authors gratefully acknowledge the statistical advice 
generously given by Dr Karen Vines, Senior Lecturer in Statistics at The Open 
University.
Contributors HAV, RLP, AP and DJG were involved in the study design. HAV was 
primarily involved with the acquisition of data and recruitment of subjects. EW was 
responsible for the statistical analysis and interpretation of data for the work. RLP, 
GVF and DJG were responsible for ophthalmic examination of subjects. All authors 
gave final approval of the version to be published. 
Funding The authors have not declared a specific grant for this research from any 
funding agency in the public, commercial or not-for-profit sectors. 
Competing interests None declared.
ethics approval This study received institutional ethical approval from The Animal 
Health Trust Clinical Research Ethics Committee, Newmarket, UK (project number 
23_2013, approved 24 September 2013).
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement There are no additional unpublished data. 
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/
RefeRences
 1. Davidson HJ, Kuonen VJ. The tear film and ocular mucins. Vet 
Ophthalmol 2004;7:71–7.
 2. Holly FJ, physiology Tfilm. Tear Film Physiology. Int Ophthalmol Clin 
1987;27:2–6.
 3. Lemp MA, Blackman HJ. Ocular surface defense mechanisms. Ann 
Ophthalmol 1981;13:61–3.
 4. Featherstone HJ, Heinrich CL. Ophthalmic examination and 
diagnostics. Part 1: the eye examination and diagnostic procedures. 
In: Gelatt KN, Gilger BC, Kern TJ, eds. Veterinary ophthalmology. 5th 
edn. Chichester, UK: John Wiley & Sons, 2012:568–73.
 5. Gelatt KN, Peiffer RL, Erickson JL, et al. Evaluation of tear formation 
in the dog, using a modification of the Schirmer tear test. J Am Vet 
Med Assoc 1975;166:368–70.
 6. Mouney MC, Accola PJ, Cremer J, et al. Effects of acepromazine 
maleate or morphine on tear production before, during, and after 
sevoflurane anesthesia in dogs. Am J Vet Res 2011;72:1427–30.
 7. Sanchez RF, Mellor D, Mould J. Effects of medetomidine and 
medetomidine-butorphanol combination on Schirmer tear test 1 
readings in dogs. Vet Ophthalmol 2006;9:33–7.
 8. Biricik HS, Ceylan C, Sakar M. Effects of pethidine and fentanyl on 
tear production in dogs. Vet Rec 2004;155:564–5.
 9. Soontornvipart K, Rauser P, Kecová H, et al. Effect of intravenous 
medetomidine-buprenorphine on canine tear flow. Online Journal of 
Veterinary Research 2003;7:10–16.
 10. Dodam JR, Branson KR, Martin DD. Effects of intramuscular 
sedative and opioid combinations on tear production in dogs. Vet 
Ophthalmol 1998;1:57–9.
 11. Monteiro ER, Coelho K, Bressan TF, et al. Effects of acepromazine-
morphine and acepromazine-methadone premedication on the 
minimum alveolar concentration of isoflurane in dogs. Vet Anaesth 
Analg 2016;43:27–34.
 12. Monteiro ER, Figueroa CD, Choma JC, et al. Effects of methadone, 
alone or in combination with acepromazine or xylazine, on sedation 
and physiologic values in dogs. Vet Anaesth Analg 2008;35:519–27.
 13. Bitti FS, Campagnol D, Rangel JP, et al. Effects of three 
methadone doses combined with acepromazine on sedation 
and some cardiopulmonary variables in dogs. Vet Anaesth Analg 
2017;44:237–45.
 14. Saito A, Kotani T. Estimation of lacrimal level and testing methods on 
normal beagles. Vet Ophthalmol 2001;4:7–11.
 15. Hamor RE, Roberts SM, Severin GA, et al. Evaluation of results for 
Schirmer tear tests conducted with and without application of a 















7Volk HA, et al. Vet Rec Open 2018;5:e000298. doi:10.1136/vetreco-2018-000298
topical anesthetic in clinically normal dogs of 5 breeds. Am J Vet 
Res 2000;61:1422–5.
 16. Hirsh SG, Kaswan RL. A comparative study of Schirmer Tear 
Test strips in dogs. Veterinary & Comparative Ophthalmology 
1995;5:215–7.
 17. Wyman M, Gilger B, Mueller P, et al. Clinical evaluation of a 
new Schirmer tear test in the dog. Veterinary & Comparative 
Ophthalmology 1995;5:211–4.
 18. Sansom J, Barnett KC. Keratoconjunctivitis sicca in the dog: a 
review of two hundred cases. J Small Anim Pract 1985;26:121–31.
 19. Park YW, Son WG, Jeong MB, et al. Evaluation of risk factors for 
development of corneal ulcer after nonocular surgery in dogs: 14 
cases (2009-2011). J Am Vet Med Assoc 2013;242:1544–8.
 20. Clarke K. Anaesthesia of the dog. In: Trim CM, Hall LW, eds. 
Veterinary anaesthesia. 11th edn. Oxford: W.B. Saunders, 
2014:405–98.
 21. Mohammad-Zadeh LF, Moses L, Gwaltney-Brant SM. Serotonin: a 
review. J Vet Pharmacol Ther 2008;31:187–99.
 22. Ghaffari MS, Madani S, Trbolova A, et al. Effects of intramuscular 
chlorpromazine alone and chlorpromazine–morphine combination on 
Schirmer tear test results in clinically normal dogs. Comp Clin Path 
2011;20:413–5.
 23. Dartt DA. Regulation of tear secretion. Adv Exp Med Biol 
1994;350:1–9.
 24. Hartley C, Williams DL, Adams VJ. Effect of age, gender, weight, 
and time of day on tear production in normal dogs. Vet Ophthalmol 
2006;9:53–7.
 25. Giannetto C, Piccione G, Giudice E. Daytime profile of the intraocular 
pressure and tear production in normal dog. Vet Ophthalmol 
2009;12:302–5.
 26. Piccione G, Giannetto C, Fazio F, et al. Daily rhythm of tear 
production in normal dog maintained under different Light/Dark 
cycles. Res Vet Sci 2009;86:521–4.
 27. Chandler JA, van der Woerdt A, Prittie JE, et al. Preliminary 
evaluation of tear production in dogs hospitalized in an intensive 
care unit. J Vet Emerg Crit Care 2013;23:274–9.








pen: first published as 10.1136/vetreco-2018-000298 on 5 D
ecem
ber 2018. D
ow
nloaded from
 
